This message contains images. If you don't see images, click here to view.
Click here to advertise in this news brief.




  Mobile version   RSS   Subscribe   Unsubscribe   Archive   Media Kit Aug. 21, 2012


 

FDA investigates codeine safety after children's deaths
ABC News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The Food and Drug Administration announced that it was investigating the safety of codeine for post-operative pain relief in children following reports of three deaths and one life-threatening emergency related to its use after tonsil surgery. The children were between the ages of 2 and 5. All had received standard doses of codeine, but doctors believe each had a genetic trait that caused them to develop toxic levels of drug in their bodies. More

 Policy and Reform


Major pharmacies to tout benefits of healthcare reform law for seniors
The Hill    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Prominent pharmacies such as CVS Caremark and Walgreens will promote the healthcare reform law's benefits for seniors, federal health officials announced. The joint effort between the Department of Health and Human Services and major pharmacy chains means Medicare beneficiaries will have better access to details about the administration's health law, HHS stated. More

Pharmacists applaud chemo guidelines for obese patients
Pharmacy Practice News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The American Society of Clinical Oncology has released guidelines recommending that physicians and pharmacists use an obese patient's actual body weight, rather than ideal body weight, to calculate the appropriate dose of nearly all chemotherapy drugs. Although many pharmacists were already following this practice, the guidelines provide clarity and support. "We were already dosing based on actual body weight prior to their release, but I think guidelines like this needed to be published and I am so glad we have them," said Leigh Boehmer, PharmD, BCOP, a clinical pharmacist in medical oncology at Barnes-Jewish Hospital in St. Louis. More

 In the News


Drug adherence and treatment improved by specialized HIV community pharmacies
Medical News Today    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Community pharmacies with specially trained staff to provide HIV services can help HIV-infected individuals be more compliant with their essential antiviral drug regimens and hence improve patient outcomes. Users of HIV-specialized Walgreen pharmacies across the U.S. had significantly greater adherence to and persistence with their therapeutic drug regimens according to a study published in AIDS Patient Care and STDs, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers. More

Kroger installing health kiosks in its pharmacies
Louisville Morning Call    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The Kroger Co. is placing self-use health-screening kiosks in all of its 1,950 pharmacy locations. The Cincinnati Business Courier reports that Kroger HealthCenter kiosks, provided by Stayhealthy Inc., give customers a free way to measure blood pressure, weight, body composition, body mass index, color vision and the ability to upload blood glucose numbers and other biometric data. More

Study: Few epilepsy patients aware of fracture risk associated with AEDs
Pharmacy Times    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Patients who take antiepileptic drugs are at increased risk for falls and fractures. Many have no idea, according to the results of a study published in a recent edition of Neurology. Falls were a common event among epilepsy patients in the study, and the fall-to-fracture ratio was quite high. Most of the falls documented in the study occurred with no warning during regular activities of daily living, and very few participants identified a cause or an obstacle associated with a fall. More

 FDA Approvals


FDA OKs 'talking' injector
MedPage Today    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The FDA has approved the first voice-guided epinephrine injection device, Auvi-Q, for treatment of severe allergic reactions. The device, which gives verbal step-by-step instructions, can be used by children weighing at least 33 pounds who are at risk for, or have a history of, anaphylaxis. More

FDA approves new flu vaccine for 2012-2013 season
The Associated Press via CBS News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The new flu vaccine for the upcoming 2012-2013 influenza season has been approved by the Food and Drug Administration. Each year the FDA works with the Centers for Disease Control and Prevention and the World Health Organization to design a vaccine to protect against the three viral strains most likely to cause the flu in the upcoming year. This year's vaccine has one strain in common with last year's vaccine, plus two new viral strains it's targeting. More

FDA OKs generic Actos for type 2 diabetes
WebMD    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The FDA approved the first generic version of Actos to treat adults with type 2 diabetes. The generic tablets use the same active ingredient as Actos, called pioglitazone, to improve blood glucose control in adults with type 2 diabetes. More

 Recalls


Hospira recalls 3 propofol lots
American Society of Health-System Pharmacists    Share    Share on FacebookTwitterShare on LinkedinE-mail article
A "supplier glass defect" — visible particles embedded in glass vials — has again prompted a recall of pharmaceuticals by Hospira Inc. This time the product is propofol injectable emulsion, 1 g in 100 mL. FDA recently circulated a press release in which Hospira announced it was recalling propofol injection lots 07-893-DJ, 10-123-DJ, and 10-125-DJ. More

Carpuject hydromorphone prefilled syringes recalled
Medscape News (free subscription)    Share    Share on FacebookTwitterShare on LinkedinE-mail article
A voluntary user level recall of one lot of hydromorphone injection, USP, 2 mg/mL, 1 mL fill in 2.5 mL Carpuject, NDC 0409-1312-30, manufactured by Hospira, has been issued by the Food and Drug Administration and the company because of a reported complaint of a single unit containing more than the 1 mL labeled fill volume. The recall comes after an FDA advisory warning that urged healthcare providers to visually inspect about 46 million units of Hospira Carpuject prefilled cartridges for overfill. Included in that advisory were prefilled syringes containing several drugs, one of which was hydromorphone. More


 

AzPA Pharmacy Flash
Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Danielle Wegert, Content Editor, 469.420.2696   
Contribute news

This edition of the AzPA Pharmacy Flash was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here — it's free!
Recent issues
Aug. 21, 2012
Aug. 14, 2012




7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063